| Literature DB >> 23687507 |
A Mézière1, M Blachier, S Thomas, M Verny, S Herbaud, O Bouillanne, O Henry, J P David, A Le Thuaut, F Canouï-Poitrine, E Paillaud.
Abstract
BACKGROUND/AIMS: We determined the prevalence of neuropsychiatric symptoms in geriatric rehabilitation patients to compare neuropsychiatric symptoms between patients with and without dementia, and to evaluate associations linking severity of cognitive impairment and neuropsychiatric symptoms.Entities:
Keywords: Dementia and neuropsychology; Neuropsychiatric symptoms; Rehabilitation
Year: 2013 PMID: 23687507 PMCID: PMC3656668 DOI: 10.1159/000350805
Source DB: PubMed Journal: Dement Geriatr Cogn Dis Extra ISSN: 1664-5464
Main characteristics of the 194 inpatients
| Overall (n = 194) | Dementia (n = 149) | No dementia(n = 45) | P | |
|---|---|---|---|---|
| Women, n (%) | 130 (67.0) | 101 (67.8) | 29 (64.4) | 0.68 |
| Mean age ± SD, years | 84.6 ± 8.0 | 84.5 ± 8.6 | 84.7 ± 5.7 | 0.63 |
| Living arrangements, n (%) | ||||
| Nursing home | 18 (9.4) | 16 (10.8) | 2 (4.5) | |
| At home alone without help | 34 (17.7) | 26 (17.6) | 8 (18.3) | 0.74 |
| At home alone with help | 59 (30.7) | 45 (30.4) | 14 (31.8) | |
| Living with family | 81 (42.2) | 61 (41.2) | 20 (45.4) | |
| Input mode to rehabilitation care, n (%) | ||||
| Acute geriatric unit | 51 (26.4) | 35 (23.5) | 16 (36.4) | 0.26 |
| Other acute units | 132 (68.4) | 106 (71.1) | 26 (59.1) | |
| Home | 10 (5.2) | 8 (5.4) | 2 (4.5) | |
| Median length of stay (25th–75th percentile), days | 66.5 (19.5–229) | 85 (25–241.5) | 40.5 (16–122) | 0.05 |
| Patient outcome, n (%) | ||||
| Home | 65 (36.1) | 40 (29.2) | 25 (58.2) | |
| Transfer to another unit | 9 (5.0) | 7 (5.1) | 2 (4.6) | 0.004 |
| Death | 21 (11.7) | 16 (11.7) | 5 (11.6) | |
| Nursing home | 85 (47.2) | 74 (54.0) | 11 (25.6) |
Seven patients had no information on their dementia status.
Orthopedics, cardiology, internal medicine, neurology, rheumatology, oncology, or hematology.
p values were estimated using the Pearson χ2 test or Fisher exact test or Student t test or Wilcoxon Mann-Whitney test.
Prevalences of neuropsychiatric subsyndromes in the 194 inpatients
| Overall (n = 194) | Percent (95% CI) | Dementia (n = 149) | Percent (95% CI) | No dementia (n = 45) | Percent (95% CI) | p | |
|---|---|---|---|---|---|---|---|
| Psychosis | 56 | 28.9 (22–35.6) | 47 | 31.5 (24.0–39.1) | 9 | 20.0 (7.8–32.1) | 0.13 |
| Affective symptoms | 89 | 45.9 (38.7–53.1) | 68 | 45.6 (37.5–53.7) | 21 | 46.7 (31.5–61.8) | 0.90 |
| Hyperactivity | 88 | 45.4 (38.2–52.6) | 80 | 53.7 (45.6–61.8) | 8 | 17.8 (6.2–29.4) | <0.001 |
| Apathy | 87 | 44.8 (37.7–52.1) | 71 | 47.6 (39.5–55.8) | 16 | 35.6 (21.0–50.1) | 0.15 |
p values were estimated using the Pearson χ2 test.
Fig. 1Comparison of neuropsychiatric symptom frequencies in inpatients with and without dementia. * p = 0.05; † p = 0.01; ‡ p = 0.001. p values were estimated using the Pearson χ2 test.
Univariate analysis of association linking cognitive impairment severity and neuropsychiatric subsyndromes
| Affective symptoms (n = 89) | Psychosis (n = 56) | Hyperactivity (n = 88) | Apathy (n = 87) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| yes (n = 68) | no | p | yes (n = 47) | no | p | yes (n = 80) | no | p | yes (n = 71) | no | p | |
| MMSE 21–30 | 28.8% | 18.2% | 0.30 | 37.8% | 16.1% | 0.02 | 20.9% | 25.5% | 0.01 | 22.6% | 23.1% | 0.97 |
| MMSE 11–20 | 42.3% | 42.4% | 29.7% | 48.1% | 32.8% | 54.9% | 41.5% | 43.1% | ||||
| MMSE 0–10 | 28.8% | 39.4% | 32.4% | 35.8% | 46.3% | 19.6% | 35.8% | 33.8% | ||||
p values were estimated using the Pearson χ2 test or Fisher exact test.
Comparison of our data of elderly inpatients to data of elderly outpatients in previous American and European studies
| Our study | CHS | MAASBED | REAL1.FR/REAL2.FR | EADC | |
|---|---|---|---|---|---|
| Study population, n | 194 | 1,508 | 199 | 255/244 | 2,808 |
| Patients with dementia, n | 149 | 682 | 199 | 499 | 2,354 |
| Mean age, years | 84.6 | 76 | 77.6 | 77.6/77.2 | 76.5 |
| Mean MMSE score (/30) | 13.4 | - | 18.1 | 16.7/23.4 | 17.6 |
| At least one neuropsychiatric symptom, % | 79.4 | 75 | 95 | 92.5/84.0 | - |
| Delusions, % | 17.5 | 18 | 21.6 | 24.7/10.2 | 19.4 |
| Hallucinations, % | 10.7 | 10.5 | 9.5 | 7.8/5.7 | 9.1 |
| Agitation, % | 36.9 | 30.3 | 18.6 | 44.3/32.8 | 31.1 |
| Depression, % | 32.9 | 32.3 | 35.2 | 42.7/36.9 | 36.7 |
| Anxiety, % | 30.4 | 21.5 | 21.1 | 46.3/44.3 | 37 |
| Euphoria, % | 3.4 | 3.1 | 3.5 | 9.8/4.5 | 4.9 |
| Disinhibition, % | 12.1 | 12.7 | 6 | 13.3/10.2 | 9.5 |
| Irritability, % | 20.9 | 27 | 23.6 | 25/28.3 | 32.1 |
| Apathy, % | 29.5 | 35.9 | 40.2 | 63.5/48.9 | 55.2 |
| Aberrant motor behavior, % | 20.8 | 16 | 25.6 | 29.8/14.7 | 27.5 |
| Sleep disturbances, % | 14.8 | 27 | 13.1 | 12.9/13.5 | 19.5 |
| Eating disturbances, % | 31.5 | 19.6 | 22 | 24.3/20.5 | 22 |
CHS = Cardiovascular Health Study; MAASBED = Maastricht Study of Behaviour in Dementia; REAL.FR = Réseau français sur la maladie d'Alzheimer.